e-learning
resources
Vienna 2009
Sunday, 13.09.2009
Bronchiolitis obliterans syndrome after lung transplantation: pathophysiology and treatment options
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lymphocytic bronchiolitis after lung transplantation: a role for azithromycin?
R. Vos, B. Vanaudenaerde, S. De Vleeschauwer, A. Willems-Widyastuti, A. Schoonis, D. Van Raemdonck, L. Dupont, G. Verleden (Leuven, Belgium)
Source:
Annual Congress 2009 - Bronchiolitis obliterans syndrome after lung transplantation: pathophysiology and treatment options
Session:
Bronchiolitis obliterans syndrome after lung transplantation: pathophysiology and treatment options
Session type:
Oral Presentation
Number:
180
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Vos, B. Vanaudenaerde, S. De Vleeschauwer, A. Willems-Widyastuti, A. Schoonis, D. Van Raemdonck, L. Dupont, G. Verleden (Leuven, Belgium). Lymphocytic bronchiolitis after lung transplantation: a role for azithromycin?. Eur Respir J 2009; 34: Suppl. 53, 180
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The physiology of breathlessness
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Azithromycin and bronchiolitis obliterans syndrome after lung transplantation: is prevention better than cure?
Source: Eur Respir J 2011; 37: 10-12
Year: 2011
Does colonization with
pseudomonas
affects the prevalence of bronchiolitis obliterans syndrome after lung transplantation?
Source: Annual Congress 2006 - Dealing with chronic allograft dysfunction: mission impossible?
Year: 2006
A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation
Source: Eur Respir J 2011; 37: 164-172
Year: 2011
A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy
Source: Eur Respir J 2008; 32: 832-842
Year: 2008
Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation?
Source: Eur Respir J 2008; 31: 1037-1045
Year: 2008
Chronic lung allograft rejection: prevalence, pathology, risk factors and pathophysiology
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=1
Year: 2004
Exploring the BAL profile in acute rejection and lymphocytic bronchiolitis after lung transplantation
Source: Annual Congress 2009 - Bronchiolitis obliterans syndrome after lung transplantation: pathophysiology and treatment options
Year: 2009
Infection and bronchiolitis obliterans syndrome in lung transplant recipients
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=44
Year: 2004
Total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014
Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal?
Source: Eur Respir J 2005; 25: 221-224
Year: 2005
Short-term variation of lung function and airway inflammation in children and adolescents with bronchiolitis obliterans
Source: International Congress 2016 – Orphan diseases I
Year: 2016
Lung transplantation: the ideal treatment for diffuse disease?
Source: Annual Congress 2006 - Up to date management of bronchiectasis
Year: 2006
Fourth lung transplantation for bronchiolitis obliterans in a patient with cystic fibrosis
Source: Annual Congress 2007 - Complications and success in lung transplantation
Year: 2007
Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans
Source: Eur Respir J 2004; 23: 384-390
Year: 2004
The role of azithromycin after lung transplantation
Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease
Year: 2012
Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study
Source: Eur Respir J 2005; 25: 490-493
Year: 2005
Validation of a bronchiolitis obliterans rat lung transplant model: the role of MMP-9
Source: Eur Respir J 2006; 28: Suppl. 50, 778s
Year: 2006
LATE-BREAKING ABSTRACT: Nitrogen multiple breath washout for diagnosis of biopsy-proven bronchiolitis obliterans in patients after allogeneic stem cell transplantation
Source: International Congress 2016 – Dyspnoea and respiratory muscle/mechanics anomalies in disease
Year: 2016
Introduction: new therapeutic approaches to bronchiolitis obliterans
Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation
Year: 2005
The Leuven experience with a dichotomy in Bronchiolitis Obliterans Syndrome (BOS) after lung transplantation revealed by azithromycin
Source: Eur Respir Rev 2008; 17: 93-95
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept